Background

D. Scott Phoenix is an American technology entrepreneur and venture capitalist who has become one of the most public-facing advocates of the human-AI merger framing of brain-computer interface technology. He co-founded Vicarious, the artificial intelligence research company building core principles in the brain to create human-like AI. Vicarious raised approximately $250 million from investors including Elon Musk and Mark Zuckerberg before being acquired by Alphabet in 2022. Phoenix is currently a Partner at Fifty Years, a deep tech pre-seed and seed-stage venture capital firm based in San Francisco, where his investment thesis focuses on facilitating a safe transition to a post-AGI world through hard tech, synthetic biology, and brain-computer interfaces.

TED 2026 framing

Phoenix’s TED 2026 talk in Vancouver established him as the most quotable public proponent of the human-AI merger thesis. The talk articulated a four-rung connection-count ladder for BCI capability scaling: 1,000 connections to restore movement, 10,000 to restore speech, and one million connections at which the field moves from restoring what was lost to adding what was never there. His verbatim closing line (“at a million connections, you stop restoring what was lost and you start adding what was never there”) is widely quoted in BCI press as the cleanest articulation of the augmentation horizon.

Phoenix’s broader strategic argument is that humans must integrate with AI to remain relevant in a world of superhuman artificial intelligence. He has used the comparison of humans keeping chimpanzees in cages “to protect them” to frame the case for biological-synthetic intelligence integration, a rhetorical move that has been both widely cited and substantively challenged.

Politico anchor

Phoenix served as the opening anchor of Politico magazine’s 15 May 2026 “Silicon Valley Wants to Put a Chip in Your Brain” feature, which positioned his TED quotes at the centre of the broader Silicon Valley transhumanism narrative. The feature’s framing has since been engaged across BCI press as the dominant English-language mainstream framing of the BCI policy debate.

Strategic position

Phoenix is the most public-facing exponent of the human-AI merger framing in the BCI category. His positioning is structurally different from clinical-stage BCI executives (who are commercialising therapeutic devices for specific patient populations) and from the broader AI infrastructure community (which is building computational systems without explicit BCI integration plans). He is one of a small number of named voices defining the cultural register through which mainstream press covers BCI policy.